Morning trading August 6, page-13

More NSB press again overnight.
It's a bloody game changer. Proud of the company, and delighted for MS sufferers in my city, and all over the planet.
$18M with $300M+ easy val. $3.3M in bank. Searing through trials and verification of their IP, EmtinB. Wish they would scream their achievements off the rooftops more, but, management are being dutifully meticulous, methodical and cautious as they bring in the big fish!
23c-27c, easy trade. $$$$$
https://themarketherald.com.au/neuroscientific-biopharmaceuticals-asxnsb-confirms-positive-ms-study-results-2020-08-05/